Snowden Capital Advisors’s Evogene EVGN Stock Holding History

Snowden Capital Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20	Closed	–	–	1355
2021 Q4	$0	Buy	+20	New	+$454	﹤0.01%	2069

Other funds holding EVGN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Snowden Capital Advisors's EVGN Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Evogene (EVGN) in Q1 2022, closing a stake of 20 shares.

Snowden Capital Advisors first reported a position in EVGN in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 38 funds tracked by Wall St. Rank hold EVGN as of Q1 2022.

Snowden Capital Advisors reported no remaining Evogene position as of Q1 2022 after selling out during the quarter.
Snowden Capital Advisors sold 20 Evogene shares in Q1 2022.
Snowden Capital Advisors first reported a position in Evogene in Q4 2021 and held it in 1 quarter.
Snowden Capital Advisors's Evogene position peaked at $0 in Q4 2021.
38 funds tracked by Wall St. Rank held Evogene as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.